Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible,announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication of the Quanta Dialysis System, a compact and easy-to-use hemodialysis device.
XRP Healthcare and Spiritus Medical is thrilled to announce their strategic collaboration, set to transform the healthcare landscape in Africa. This groundbreaking partnership aims to bring cutting-edge medical technology to the region,starting with the integration of the SPIRITUS VITALITY Ventilator into newly acquired medical facilities in East Africa, with Uganda as the initial focus.
PacBio a leading developer of high-quality, highly accurate sequencing solutions, announced that customer shipments of Onso short-read sequencing instruments will commenc.
Fresenius Kabi announced that its Ivenix® Infusion System has been selected by the Metrodora Institute to meet the Institute’s infusion medicine needs. The Metrodora Institute is an integrated, multidisciplinary medical and research center dedicated to treating neuroimmune axis disorders.
Thermo Fisher Scientific, the world leader in serving science, announced the launch of the Gibco™ OncoPro™ Tumoroid Culture Medium Kit*, the first commercially available culture medium specifically developed for the expansion of patient-derived tumoroids, or cancer organoids, from multiple cancer indications.
Kindbody, a leading fertility clinic network and family-building benefits provider for employers, announced the launch of Kindlabs, its in-house genetic testing division.
Portable Medical Equipment (PME) such as IV pumps, workstations on wheels (WOWs), and vitals machines can carry and transfer dangerous pathogens between rooms and patients within healthcare facilities because the equipment is often used and rolled between multiple patient rooms.
Nikon Instruments Inc. is pleased to announce the development and launch of the "ECLIPSE Ui", an integrated microscope-based viewing system designed for both in-person clinical and remote pathological observation.
W. L. Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, non-randomized, multicenter, single-arm study with five-year follow-up (NCT05489588) to evaluate the investigational GORE® VIAFORT Vascular Stent for the treatment of symptomatic iliofemoral venous obstruction.
Esaote North America, Inc. is proud to announce the release of their new veterinary MyLab™X90VET ultrasound system, now available for purchase in North America.